VistaGen Therapeutics News - VTGN

Company Name	Stock Ticker Symbol	Market	Type
VistaGen Therapeutics Inc	VTGN	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	4.83	07:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				4.83

more quote information »

Recent News

Date	Time	Source	Heading
4/09/2024	08:30	BW	Vistagen to Present at the 2024 Anxiety and Depression..
4/01/2024	08:30	BW	Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol..
3/11/2024	08:30	BW	Vistagen to Present at Stifel 2024 Virtual CNS Days
3/06/2024	18:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/06/2024	18:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/06/2024	18:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/06/2024	18:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2/28/2024	08:30	BW	Vistagen to Present at TD Cowen 44th Annual Health Care..
2/14/2024	18:18	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	16:51	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/14/2024	08:56	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	16:52	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2/13/2024	16:33	EDGAR2	Form 8-K - Current report
2/13/2024	16:25	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/13/2024	16:20	BW	Vistagen Reports Fiscal 2024 Third Quarter Financial Results..
2/06/2024	08:30	BW	Vistagen to Report Fiscal Year 2024 Third Quarter Financial..
1/03/2024	17:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	17:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	17:09	EDGAR2	Form 8-K - Current report
12/27/2023	08:30	BW	Vistagen Receives Notice from European Patent Office of..
11/09/2023	16:44	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:42	EDGAR2	Form 8-K - Current report
11/09/2023	16:30	BW	Vistagen Provides Corporate Update and Reports Fiscal 2024..
11/08/2023	08:30	BW	Vistagen to Present at Stifel 2023 Healthcare Conference
11/07/2023	08:30	BW	Vistagen to Present Positive Fasedienol Phase 3 Data and..
11/06/2023	21:46	EDGAR2	Form 8-K/A - Current report: [Amend]
11/06/2023	16:27	EDGAR2	Form 8-K - Current report
11/06/2023	08:00	BW	Vistagen To Report Second Quarter Financial Results and Host..
11/03/2023	20:14	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/26/2023	16:13	EDGAR2	Form 8-K - Current report
10/16/2023	16:37	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
10/16/2023	16:01	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
10/06/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/06/2023	16:05	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
10/05/2023	16:47	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
10/05/2023	08:30	BW	Vistagen to Present at Jefferies Inaugural Biotech CNS/Neuro..
10/04/2023	16:07	EDGAR2	Form 8-K - Current report
10/03/2023	16:40	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/2023	07:30	BW	Vistagen Announces Pricing of $100 Million Underwritten..
10/02/2023	07:15	EDGAR2	Form 8-K - Current report
9/29/2023	16:26	EDGAR2	Form 8-K - Current report
9/12/2023	08:30	BW	Vistagen Announces Positive Results from Exploratory Phase..
9/08/2023	17:27	EDGAR2	Form 8-K - Current report
9/05/2023	09:00	BW	Vistagen and Fuji Enter Exclusive Negotiation Agreement for..
8/23/2023	13:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/23/2023	13:08	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/22/2023	08:40	EDGAR2	Form 8-K - Current report
8/22/2023	08:30	BW	Vistagen Appoints Cindy Anderson as Chief Financial Officer
8/10/2023	17:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]